Protective Effect of Electroacupuncture on Lung in Patients Undergoing General Anesthesia

August 20, 2021 updated by: Lingling Ding
Objective to investigate the protective effect of preoperative electroacupuncture on lung function in patients with mechanical ventilation for more than 2 hours under general anesthesia

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Randomized parallel control study. From September 1, 2021 to December 31, 2022, patients with mechanical ventilation time more than 2 hours will be randomly divided into electroacupuncture pretreatment group and blank control group. The blood gas index, ventilator parameters and serum inflammatory factor concentration of patients will be evaluated to evaluate whether electroacupuncture has protective effect on lung function of patients with mechanical ventilation.

Study Type

Interventional

Enrollment (Anticipated)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing general anesthesia in our hospital;
  • Ages 18-60;
  • American Society of Anesthesiologists (ASA) grade ⅱ ~ III , no severe respiratory, circulation, liver, kidney, coagulation function abnormalities;
  • Expected duration of operation >2h;
  • Surgical grade 2-4;
  • No serious lung infection and lung disease;
  • Body mass index (BMI) 18~30 kg/m2; There are no contraindications for electroacupuncture stimulation.

Exclusion Criteria:

  • Patients with severe circulatory or other system dysfunction;
  • Patients with pulmonary and one-lung ventilation;
  • Unwilling to cooperate with the patient;
  • Patients with low compliance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: electroacupuncture group
In the electroacupuncture group, acupoints of Lieque (+), Chize (-), Sanyinjiao (-), Zusanli (+), Tanzhong (+) and Yutang (-) will be selected for electrical stimulation. Density wave will be selected, and the current intensity should be tolerated by the patients. Conventional anesthesia operation could be started after the connection of electroacupuncture, and acupuncture point stimulation was stopped 30min later.
In the electroacupuncture group, acupoints of Lieque (+), Chize (-), Sanyinjiao (-), Zusanli (+), Tanzhong (+) and Yutang (-) will be selected for electrical stimulation. Density wave will be selected, and the current intensity should be tolerated by the patients. Conventional anesthesia operation could be started after the connection of electroacupuncture, and acupuncture point stimulation will be stopped 30min later.
No Intervention: control group
The patient underwent routine anesthesia without acupuncture treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oxygenation index
Time Frame: Before anesthesia
record oxygenation index
Before anesthesia
oxygenation index
Time Frame: 2 hours after tracheal intubation
record oxygenation index
2 hours after tracheal intubation
oxygenation index
Time Frame: 5 minutes after tracheal intubation removal
record oxygenation index
5 minutes after tracheal intubation removal

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative comfort score
Time Frame: during anesthesia recovery period
Assess the quality of recovery during recovery
during anesthesia recovery period
sedation score (Ramsay)
Time Frame: during anesthesia recovery period
Assess the quality of recovery during recovery
during anesthesia recovery period
restfulness score (DRS)
Time Frame: during anesthesia recovery period
Assess the quality of recovery during recovery
during anesthesia recovery period
visual analogue scale (VAS)
Time Frame: during anesthesia recovery period
Assess the quality of recovery during recovery
during anesthesia recovery period
Length of stay
Time Frame: 1 week after discharge, the patient's length of stay will be recorded through medical record system
Assess the quality of postoperative recovery
1 week after discharge, the patient's length of stay will be recorded through medical record system
postoperative time in hospital
Time Frame: 1 week after discharge, the patient's postoperative time in hospital will be recorded through medical record system
Assess the quality of postoperative recovery
1 week after discharge, the patient's postoperative time in hospital will be recorded through medical record system
postoperative complications of major organs
Time Frame: Major organ complications during hospitalization,assessed up to 30 days after surgery
Assess the quality of postoperative recovery
Major organ complications during hospitalization,assessed up to 30 days after surgery
mortality within 30 days
Time Frame: mortality within 30 days will be recorded
Assess the quality of postoperative recovery
mortality within 30 days will be recorded
Expression of IL-18 in serum
Time Frame: Before anesthetic induction the radial artery blood samples will be collected, and the expressions of IL-18 in serum will be detected by flow cytometry
The perioperative inflammation level will be assessed
Before anesthetic induction the radial artery blood samples will be collected, and the expressions of IL-18 in serum will be detected by flow cytometry
Expression of IL-18 in serum
Time Frame: 5minutes after tracheal intubation removal the radial artery blood samples will be collected, and the expressions of IL-18 in serum will be detected by flow cytometry
The perioperative inflammation level will be assessed
5minutes after tracheal intubation removal the radial artery blood samples will be collected, and the expressions of IL-18 in serum will be detected by flow cytometry
Expression of IL-1β in serum
Time Frame: Before anesthetic induction the radial artery blood samples will be collected, and the expressions of IL-1β in serum will be detected by flow cytometry
The perioperative inflammation level will be assessed
Before anesthetic induction the radial artery blood samples will be collected, and the expressions of IL-1β in serum will be detected by flow cytometry
Expression of IL-1β in serum
Time Frame: 5minutes after tracheal intubation removal the radial artery blood samples will be collected, and the expressions of IL-1β in serum will be detected by flow cytometry
The perioperative inflammation level will be assessed
5minutes after tracheal intubation removal the radial artery blood samples will be collected, and the expressions of IL-1β in serum will be detected by flow cytometry
Expression of IL-10 in serum
Time Frame: Before anesthetic induction the radial artery blood samples will be collected, and the expressions of IL-10 in serum will be detected by flow cytometry
The perioperative inflammation level will be assessed
Before anesthetic induction the radial artery blood samples will be collected, and the expressions of IL-10 in serum will be detected by flow cytometry
Expression of IL-10 in serum
Time Frame: 5minutes after tracheal intubation removal the radial artery blood samples will be collected, and the expressions of IL-10 in serum will be detected by flow cytometry
The perioperative inflammation level will be assessed
5minutes after tracheal intubation removal the radial artery blood samples will be collected, and the expressions of IL-10 in serum will be detected by flow cytometry
Mean arterial pressure
Time Frame: Before anesthesia ,2 hours after tracheal intubation , and 5minutes after tracheal intubation removal
Intraoperative vital signs will be recorded
Before anesthesia ,2 hours after tracheal intubation , and 5minutes after tracheal intubation removal
heart rate
Time Frame: Before anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removal
Intraoperative vital signs will be recorded
Before anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removal
BIS
Time Frame: Before anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removal
Intraoperative vital signs will be recorded
Before anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removal
extubation time
Time Frame: Before anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removal
Intraoperative vital signs will be recorded
Before anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removal
anesthesia dosage
Time Frame: Before anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removal
Intraoperative vital signs will be recorded
Before anesthesia , 2 hours after tracheal intubation , and 5minutes after tracheal intubation removal

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2021

Primary Completion (Anticipated)

September 1, 2022

Study Completion (Anticipated)

September 1, 2023

Study Registration Dates

First Submitted

July 25, 2021

First Submitted That Met QC Criteria

August 20, 2021

First Posted (Actual)

August 24, 2021

Study Record Updates

Last Update Posted (Actual)

August 24, 2021

Last Update Submitted That Met QC Criteria

August 20, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Electroacupuncture

Clinical Trials on electroacupuncture

Subscribe